Serotonin syndrome induced by tramadol intoxication in an 8-month-old infant

Céline Maréchal1, Raphaele Honorat, Isabelle Claudet

  • 1Pediatric Emergency Department, Children's Hospital, Toulouse, France.

Pediatric Neurology
|December 15, 2010
PubMed

Insights

A rare case of pediatric tramadol intoxication led to serotonin syndrome in an infant. This highlights the potential for severe neurological and cardiovascular effects beyond typical opioid symptoms in children.

Area of Science:

  • Pediatric Toxicology
  • Clinical Neurology
  • Pharmacology

Background:

  • Severe tramadol intoxication in children is infrequently documented.
  • Serotonin syndrome is a known complication of tramadol, particularly when combined with other serotonergic agents in adults.

Observation:

  • An 8-month-old girl experienced severe agitation, tachycardia, and altered mental status after accidental tramadol ingestion.
  • The child subsequently developed hyperthermia and hypertension, consistent with moderate serotonin syndrome.
  • Neurologic and cardiovascular symptoms resolved within 48 hours, with no long-term sequelae.

Findings:

  • Confirmed tramadol intoxication with serum levels of 680 μg/L.
  • The patient presented with serotonin syndrome, characterized by agitation, autonomic instability, and hyperreflexia, rather than the typical opioid effects or seizures seen in pediatric tramadol cases.
  • This case demonstrates an unusual presentation of tramadol toxicity in a pediatric patient.

Implications:

  • Pediatric healthcare providers should consider serotonin syndrome in the differential diagnosis of tramadol intoxication, even in the absence of co-ingestions.
  • This case underscores the importance of recognizing tramadol's serotonergic activity in pediatric poisoning.
  • Further research into the specific mechanisms and prevalence of serotonin syndrome from tramadol in children is warranted.

Related Concept Videos

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...